Effect of Rosiglitazone on ADMA in Critical Illness
Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Rosiglitazone,decreases the ADMA
concentration and thereby increases the arginine/ADMA ratio of critically ill patients.